BARD ACCESS SYSTEMS POWERPORT ISP M.R.I. IMPLANTABLE PORT, GROSHONG SINGLE-LUMEN, 8F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
|
Back to Search Results |
|
Model Number 1808560 |
Device Problems
Fracture (1260); Migration or Expulsion of Device (1395); Material Separation (1562)
|
Patient Problem
Injury (2348)
|
Event Date 07/23/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
As the lot number for the device was provided, a review of the device history records is currently being performed.The device has been returned to the manufacturer and the evaluation is still pending.The investigation of the reported event is currently underway.Expiry date (03/2023).
|
|
Event Description
|
It was reported during port placement procedure, the device allegedly broke.It was further reported that, cardiac catheterization intervention was required to remove broken pieced from patient.Reportedly, another device was used to complete the procedure.The patient current status was good.
|
|
Event Description
|
It was reported during port placement procedure, the device allegedly broke.It was further reported that, cardiac catheterization intervention was required to remove broken pieced from patient.Reportedly, another device was used to complete the procedure.The patient current status was good.
|
|
Manufacturer Narrative
|
H10: manufacturing review: a lot history review was performed.This is the only complaint to date for this lot number.Therefore, a device history record review is not required.Investigation summary: one groshong catheter returned in two segments were returned for evaluation.Visual, microscopic and functional evaluation were performed on the device.The investigation is confirmed for the reported fracture as a complete compound break that was noted in the middle of the catheter.Further during functional evaluation both proximal and distal catheter segments were patent to infusion and aspiration without any issue.A definitive root cause could not be determined based upon available information.Labeling review: a review of product labeling documents (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) showed that the product labeling is adequate.H10: d4 (expiry date: 03/2023),g4.H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
|
Search Alerts/Recalls
|
|
|